Supernus Pharmaceuticals
SUPN
#4516
Rank
NZ$2.86 B
Marketcap
$51.93
Share price
0.91%
Change (1 day)
9.28%
Change (1 year)

Supernus Pharmaceuticals (SUPN) - Total liabilities

Total liabilities on the balance sheet as of June 2024 : NZ$0.57 B

According to Supernus Pharmaceuticals 's latest financial reports the company's total liabilities are NZ$0.57 B. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Supernus Pharmaceuticals - Total liabilities on balance sheet (from 2009 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31NZ$0.56 B-56.2%
2022-12-31NZ$1.28 B0.83%
2021-12-31NZ$1.27 B20.79%
2020-12-31NZ$1.05 B26.07%
2019-12-31NZ$0.83 B7.08%
2018-12-31NZ$0.78 B253.78%
2017-12-31NZ$0.22 B29.96%
2016-12-31NZ$0.17 B15.56%
2015-12-31NZ$0.14 B20.16%
2014-12-31NZ$0.12 B29.75%
2013-12-31NZ$94.4 M112.51%
2012-12-31NZ$44.42 M-21.72%
2011-12-31NZ$56.74 M-52.26%
2010-12-31NZ$0.11 B-0.42%
2009-12-31NZ$0.11 B-17.91%
2008-12-31NZ$0.14 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
NZ$1.65 B 186.29%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$94.13 B 16,150.94%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$125.39 B 21,546.88%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$54.07 B 9,235.75%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$177.07 B 30,468.54%๐Ÿ‡บ๐Ÿ‡ธ USA